NCT03294941View on ClinicalTrials.gov

The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology

PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions
NASH - Nonalcoholic Steatohepatitis
Interventions
COMBINATION_PRODUCT

HepQuant SHUNT Liver Diagnostic Kit

Serial testing over 48 weeks

Trial Locations (8)

19104

University of PA, Philadelphia

23224

McGuire VA Med Cntr, Richmond

23298

Virginia Commonwealth University, Richmond

33136

Schiff Center for Liver Diseases, Miami

75203

Methodist Dallas Medical Center, Dallas

76092

TX Digestive Disease Consultants, Dallas

78215

The Texas Liver Institute, San Antonio

98103

University of Washingtion, Seattle

Sponsors

Lead Sponsor

HepQuant, LLC
All Listed Sponsors
lead

HepQuant, LLC

INDUSTRY

NCT03294941 - The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology | Biotech Hunter | Biotech Hunter